Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
Nieuwe richtlijn prostaatkanker: minder biopten door MRI
feb 2020 | Uro-oncologie